ImagineAR Inc.  is an augmented reality (AR) platform that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds using ImagineARTM. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The ImagineARTM Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.

Headquartered in Seattle, Washington, Jones markets and distributes premium craft beverages under the Jones® Soda and Lemoncocco® brands. A leader in the premium craft soda category, Jones is made with cane sugar and other high-quality ingredients and is known for packaging that incorporates ever-changing photos sent in from its consumers. Jones’ diverse product line offers something for everyone – cane sugar soda, zero-calorie soda and Lemoncocco non-carbonated premium refreshment. Jones is sold across North America in glass bottles, cans and on fountain through traditional beverage outlets, restaurants, and alternative accounts.

Lanebury Growth Capital Ltd. is an investment company targeting, in general, early stage technology businesses who have an entrepreneurial management team in place that have demonstrated leadership abilities with a clear strategic vision for the future. The invested capital will be in the $100,000 to $1,000,000 range and will represent a significant position giving Lanebury strong influence over corporate affairs. Lanebury will prefer that a proven monthly revenue model has been established that can be easily scaled up over a variety of software platforms used around the world.  In general, Lanebury will act like a technology incubator advisory group assisting management with their proven experience and available capital whereby forward objectives become aligned towards mutual success.

ME Therapeutics is an early stage Vancouver based biotechnology company involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. Our main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-tumour immunity.